Navigation Links
Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007

VANCOUVER and SAN DIEGO, May 18, 2007 /PRNewswire-FirstCall/ - MIGENIX Inc. , a clinical-stage developer of drugs for infectious diseases will make a presentation of results from a recent hepatitis C Phase II combination therapy study (see April 11, 2007 press release) in a non-responder patient population at Digestive Disease Week (DDW) 2007 being held in Washington, DC May 19-24, 2007. Dr. Kelly Kaita, the Director of the Viral Hepatitis Investigative Unit (VHIU) at the Health Sciences Centre, University of Manitoba and a lead investigator in the MIGENIX Phase II study will make the presentation.

The presentation entitled: "Phase II Study of Celgosivir in Combination with Peginterferon alfa-2b and Ribavirin in Chronic Hepatitis C Genotype-1 Non-responder Patients" (Abstract # 324227) will be made on Monday, May 21, at 2:45 p.m. (EDT) in Room 206 of the Washington Convention Center. Additionally on May 20, 2007 Dr. Kaita and AnnKatrin Petersen, M.D., Vice President, Clinical Development of MIGENIX will participate in a DDW news conference highlighting progress in new and evolving areas of chronic hepatitis C therapy including celgosivir. A copy of the presentation and the related Abstract will be available at www.migenix.com following the presentation.

Research being presented at Digestive Disease Week 2007 analyzes advancements in the diagnosis of hepatitis C and therapies available to patients who suffer from the disease. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Digestive Disease Week is considered the largest and most prestigious meeting in the world for the gastrointestinal professional. Every year DDW attracts more than 16,000 physicians, researchers and academics from around the world.

About Celgosivir (MX-3253)<
'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:9/29/2014)... SAN DIEGO , 29 septembre ... désignée Daiichi Sankyo) (TSE : 4568) et Ambit Biosciences ... d,un accord de fusion définitif en vertu duquel ... actions ordinaires en circulation d,Ambit Biosciences à 15 ... d,une offre publique d,achat qui sera suivie d,une ...
(Date:9/29/2014)...  Bob Pack, who lost his two young children ... Medical Association to immediately cease airing a television ad ... Mercury News called "shamelessly deceptive" and of which the ... believe about the measure is wrong." ... that doctors check California,s existing ...
(Date:9/29/2014)... Sept. 29, 2014  Volcano Corporation (Nasdaq: ... improving patient and economic outcomes on a global ... coronary and peripheral visualization, physiology diagnostics and therapies, ... Board of Directors from Engaged Capital, LLC.  The ... Volcano welcomes the perspectives of its ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3
... studied the treatment of pregnant women with hepatitis B virus ... study concluded that both the mothers benefited from treatment and ... weeks postbirth. The study presenter and co-investigator Calvin ... as hepatitis B is difficult to eradicate and currently there ...
... POINT, Calif., Nov. 1, 2010 The Global ... organization that aims to raise awareness about the ... 7,000 Bracelets for Hope™ campaign. The 7,000 Bracelets ... to an estimated 7,000 different chronic, life-threatening and ...
Cached Medicine Technology:Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants 2Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants 37,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 27,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 3
(Date:9/30/2014)... Washington, DC (PRWEB) September ... **MEDIA ADVISORY** , ... Contact:    Anne Barnwell, 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org ... Give Hope® Celebration , ... , Address:    The Army and ...
(Date:9/30/2014)... Arkansas (PRWEB) September 30, 2014 Every New Year ... wishes, dreams all worthy of 365 days of effort, however most ... are too vast or too vague. Instead of "spend more ... & Talk more. , 2. Without a reminder, daily ... on the back burner. , 3. Goals out ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Miraca Life ... will present eight research posters at the annual meeting ... ACG will hold its Annual Scientific Meeting and Postgraduate ... exhibit hall, staff from Miraca Life Sciences will be ... meeting’s Clinical Case Challenge. , The research posters for ...
(Date:9/30/2014)... Youth Town’s annual BBQ/Music Festival will take place ... at the Youth Town campus (3641 Youth Town Road ... festival, which will offer music, food and games. Admission ... show, arts and crafts fair, music, championship barbeque competition, ... McQueen and Mater from the hit Disney movie “Cars” ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 A trailblazer at ... and seeks out upcoming medical breakthroughs in spine repairs. ... has seen in his patients in which he has implanted ... and its components are state-of-the art and mimic normal human ... Mobi-C has also been proven to be an exceptional replacement ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2Health News:Miraca Life Sciences Research Institute to Present Eight GI Pathology Research Studies at Annual Meeting of American College of Gastroenterologists 2
... May 1 According to CNN and other prominent ... is high as health officials continue to raise the ... their emergency action plans before the global health threat ... checklists, which were created during the SARS and Avian ...
... Managed Pharmacy Care, Inc., is stepping forth not ... general public in several matters of emerging importance.Not only ... various counties, but it is pleased to serve as ... health-care crisis striking our country. For instance, we could ...
... to Put Yourself First When It Feels Like You Are ... Day is one time a year for families to honor ... provide. Mothers seem to put their children and family first ... like Mother,s Day are often no exception. The day designed ...
... reports leveling off of cases , , FRIDAY, May 1 (HealthDay ... the United States has now reached 141, federal health officials ... are racing to produce a vaccine for all Americans against ... at all -- wouldn,t be available until fall at the ...
... Bertalan Mesko, medical blogger and health 2.0 consultant, published a ... patients can follow all the new cases and ... interactive maps that show the exact locations of new cases, ... of useful and relevant messages. Websites providing the most accurate ...
... connection is unclear, researchers say , , FRIDAY, May 1 (HealthDay ... up two or more times a night to urinate face ... a possible explanation for the cause of the higher death ... may play a role, instead of the need to urinate ...
Cached Medicine News:Health News:Anticipating a Pandemic: Primary Research Helps Companies Review & Engage Disaster Management Plans 2Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 2Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 3Health News:Swine Flu Infections Now Top 140 in U.S. 2Health News:Swine Flu Infections Now Top 140 in U.S. 3Health News:Swine Flu Infections Now Top 140 in U.S. 4Health News:Swine Flu Infections Now Top 140 in U.S. 5Health News:Swine Flu Infections Now Top 140 in U.S. 6Health News:Swine Flu Infections Now Top 140 in U.S. 7Health News:Swine Flu Infections Now Top 140 in U.S. 8Health News:Nighttime Urination Linked to Higher Death Rate Among Elderly 2
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. It acts as a ...
... Antiseptic Antibacterial that does not ... 30 seconds, destroys over 99% ... for cleansing of minor wounds, ... disinfection of personal utensils and ...
... professional degerming, pre-op and post-op procedures. ... quaternary and substituted phenolic active ingredients ... and surfactants. Unprecedented efficacy on all ... 30 seconds. Techni-Care represents a new ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Medicine Products: